In “Product Distributor Liability: Some Different Scenarios,” an article for ID Access, I address liability for product distributors by using examples to illustrate product distributor liability in practical scenarios such as in the case of when a distributor transports E. coli-contaminated lettuce or ground beef from a producer to a retailer. Central to this writing is the concept of a pass-through statute: What pass-through statutes do–when they work as intended–is help the plaintiff to find out the identity of the manufacturer in situations where that information might otherwise be hard to learn. The statute also protects non-manufacturing defendants avoid the cost and disruption of litigation, or at least most of it.
Denis Stearns, is of-counsel at Marler Clark, earned a BA in philosophy from Seattle University, and his law degree from the University of Wisconsin at Madison. He graduated from both schools with high honors, and won numerous awards for service and
European Union reference laboratories focused on bacteria, parasites and viruses have started work.
Beginning this month, the three labs for foodborne and waterborne diseases officially began operations.
A group representing the fish sector in Europe has welcomed regulation on tuna frozen in brine.
Europêche said the legislation recognizes the high sanitary and technological standards already applied by
The Dutch poultry sector has implemented measures to try and curb a rise in Salmonella infections.
Figures show an increased incidence of Salmonella Enteritidis in laying hens since May 2023
The annual report of a system that helps ensure safe trade involving Europe has revealed the scale and reasons for rejected shipments.
TRACES is the online platform of the Directorate-General
OPINION
In an article that will soon be published in the Seattle Law Review, I take a look at food safety through the lens of the “pink slime” controversy and
“Ah, but a man’s reach should exceed his grasp, Or what’s a heaven for?”
— from Robert Browning’s “Andrea del Sarto”
Part 2: Does case law support FDA’
